Terms: = Thyroid cancer AND AR, P10275, 367, ENSG00000169083, DHTR, SBMA, HUMARA, SMAX1, RP11-383C12_1, TFM, AIS, NR3C4, KD
28477 results:
1. Discriminating Interpatient Variabilities of RAS Gene Variants for Precision Detection of thyroid cancer.
Fu G; Chazen RS; MacMillan C; Witterick IJ
JAMA Netw Open; 2024 May; 7(5):e2411919. PubMed ID: 38758552
[TBL] [Abstract] [Full Text] [Related]
2. Feasibility and complications after transoral endoscopic thyroidectomy via vestibular approach (TOETVA) - a single-center first experience case series.
Kinet S; van Weezelenburg MAS; Pijnenburg A; Stoot JHMB; van Bastelaar J
Langenbecks Arch Surg; 2024 May; 409(1):158. PubMed ID: 38748236
[TBL] [Abstract] [Full Text] [Related]
3. Coexistence of Hashimoto's thyroiditis and papillary thyroid carcinoma revisited in thyroidology, an experience from an endemic region: fad or future?
Cinar I; Sengul I
Rev Assoc Med Bras (1992); 2024; 70(4):e20231380. PubMed ID: 38747877
[TBL] [Abstract] [Full Text] [Related]
4. RPGRIP1L as a new biomarker for prognosis and tumor immune of breast cancer.
Yi J; Liu L; Chen Y; Ding T; Fan P; Yu J; Zeng J
FASEB J; 2024 May; 38(9):e23624. PubMed ID: 38747001
[TBL] [Abstract] [Full Text] [Related]
5. [The clinicopathological features of adult thyroid tumors with DICER1 mutation].
Tang J; Huang JJ; Luo YL; Zhang LK; Wang QQ; Chen J; Liu ZY
Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1623-1627. PubMed ID: 38742350
[TBL] [Abstract] [Full Text] [Related]
6. [Treatment strategy for low-risk papillary thyroid carcinoma with diameter smaller than 1 cm: immediate surgery vs active surveillance].
Sun W; Liu Q; Zhang H
Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1572-1577. PubMed ID: 38742343
[TBL] [Abstract] [Full Text] [Related]
7. WHO 2022 updates on follicular cell and c-cell derived thyroid neoplasm.
Goswami P; Patel T; Dave R; Singh G; Singh A; Kalonia T
J Med Life; 2024 Jan; 17(1):15-23. PubMed ID: 38737660
[TBL] [Abstract] [Full Text] [Related]
8. Cyclometalated and NNN Terpyridine Ruthenium Photocatalysts and Their Cytotoxic Activity.
Ballico M; Alessi D; Aneggi E; Busato M; Zuccaccia D; Allegri L; Damante G; Jandl C; Baratta W
Molecules; 2024 May; 29(9):. PubMed ID: 38731639
[TBL] [Abstract] [Full Text] [Related]
9. In situ ascending aortic thrombus in a patient with metastatic lung adenocarcinoma and no aortic atherosclerosis or cisplatin exposure: a case report.
Mehta C; Raza F
J Med Case Rep; 2024 May; 18(1):243. PubMed ID: 38730499
[TBL] [Abstract] [Full Text] [Related]
10. Do PFCAs drive the establishment of thyroid cancer microenvironment? Effects of C6O4, PFOA and PFHxA exposure in two models of human thyroid cells in primary culture.
Coperchini F; Greco A; Croce L; Teliti M; Calì B; Chytiris S; Magri F; Rotondi M
Environ Int; 2024 May; 187():108717. PubMed ID: 38728818
[TBL] [Abstract] [Full Text] [Related]
11. Columnar Cell thyroid Carcinoma: A Heterogeneous Entity Demonstrating Overlap Between Papillary thyroid Carcinoma and Follicular Neoplasms.
Higgins KE; Sadow PM; Johnson DN; Wang P; Wanjari P; Cipriani NA
Head Neck Pathol; 2024 May; 18(1):39. PubMed ID: 38727854
[TBL] [Abstract] [Full Text] [Related]
12. A Competing Risk Nomogram for Prediction of Prognosis in Patients With Primary Squamous Cell thyroid Carcinoma.
Tian Y; He L; Zhang B; Deng L; Wang J
Technol Cancer Res Treat; 2024; 23():15330338241254059. PubMed ID: 38725285
[No Abstract] [Full Text] [Related]
13.
Zang Z; Yin Y; Liu C; Zhu Q; Huang X; Li H; Yang R
Epigenetics; 2024 Dec; 19(1):2352683. PubMed ID: 38723244
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic value of postoperative anti-thyroglobulin antibody in patients with differentiated thyroid cancer.
Zhao Y; Mu Z; Liang D; Zhang T; Zhang X; Sun D; Sun Y; Liang J; Lin Y
Front Endocrinol (Lausanne); 2024; 15():1354426. PubMed ID: 38721144
[TBL] [Abstract] [Full Text] [Related]
15. Risk of Subsequent Primary cancers Among Adult-Onset 5-Year cancer Survivors in South Korea: Retrospective Cohort Study.
Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
[TBL] [Abstract] [Full Text] [Related]
16. Overweight as a biomarker for concomitant thyroid cancer in patients with Graves' disease.
Park J; An S; Bae JS; Kim JS; Kim K
Front Endocrinol (Lausanne); 2024; 15():1382124. PubMed ID: 38711981
[TBL] [Abstract] [Full Text] [Related]
17. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
[TBL] [Abstract] [Full Text] [Related]
18. Patient reported outcomes and patient experiences of immune checkpoint modulators for advanced or recurrent melanoma: a mixed methods study.
Tometich DB; Geiss C; Maconi ML; Chavez M; Hoogland AI; Li X; Nieves-Lopez A; Rodriguez Y; Bryant C; Brohl AS; Eroglu Z; Markowitz J; Tarhini AA; Hwu P; Khushalani NI; Jim HSL
Support Care Cancer; 2024 May; 32(6):330. PubMed ID: 38709312
[TBL] [Abstract] [Full Text] [Related]
19. Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
Solórzano M; Lustig N; Mosso L; Espinoza M; Santana R; Gonzalez H; Montero PH; Cruz F; Solar A; Domínguez JM
Arch Endocrinol Metab; 2024 May; 68():e230146. PubMed ID: 38709151
[TBL] [Abstract] [Full Text] [Related]
20. Significance of
Lin H; Wang J; Shi Q; Wu M
PeerJ; 2024; 12():e17338. PubMed ID: 38708353
[TBL] [Abstract] [Full Text] [Related]
[Next]
